Circadian Patterns of Myocardial Ischaemia and the Effects of Antianginal Drugs

References

• Lemmer B, ed. Chronopharmacology-cellular and biochemical interactions. New York, Basel. Marcel Dekker, 1989.
   Google Scholar
• Lemmer B. Circadian rhythms in the cardiovascular system. In: Arendt J, Minors DS, Waterhouse JM, eds. Biological rhythms in clinical practice. Chap. 4. London, Boston: Butterworths and Co., 1989:51–70.
   Google Scholar
• Millar-Craig MW, Bishop CN, Raftery EB. Circadian variation of blood pressure. Lancet 1978; 1:797–9.
   Google Scholar
• Northcote RJ, Canning GP, Ballantyne D. Electrocardiographic findings in male veteran endurance athletes. Er Heart J 1989;61:155–60.
   Google Scholar
• Partinen M. Stress and the heart: the sleep factor. Stress Med 1988;4:253–63.
   Google Scholar
• Furlan R, Guzzetti S, Crivellaro W, et al. Continuous 24 hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation 1990;81:537–47.
   PubMed Web of Science ®Google Scholar
• Pipilis A, Flather M, Ormerod O, Sleight P. Prognostic significance of heart rate variability in myocar-dial infarction. Br Hear1 J 1991; 66:61.
   Google Scholar
• McAreavey D, Neilson JMM, Ewing DJ, Russell DC. Cardiac parasympathetic activity during the early hours of acute myocardial infarction. Br Heart J 1989;62:165–70.
   PubMedGoogle Scholar
• OBrien E, Sheridan J, OMalley K. Dippers and non-dippers. Lancet 1988;2:397.
   Web of Science ®Google Scholar
• Mulcahy D, Purcell H, Fox K. Should weget up in the morning?Observations on circadian variations in cardiac events. Br Heart J 1991;65:299–301.
   PubMedGoogle Scholar
• Muller JE, Tofler GH. Introduction in a symposium: triggering and circadian variation of onset of acute cardiovascular disease. Am J Cardiol 1990;66: 1 G–6.
   Google Scholar
• Purcell HJ, Gibbs JSR. Ambulatory blood pressure monitoring and circadian variation of cardiovascular disease; clinical and research applications. J Hypertens (in press).
   Google Scholar
• Fujita M, Franklin D. Diurnal changes in coronary blood flow in conscious dogs. Circulation 1987;76:488–91.
   PubMed Web of Science ®Google Scholar
• Muller JE, Tofler GH. Circadian variation in onset of cardiovascular disease. In: Braunwald E, ed. Heart disease—a textbook of cardiovascular medicine, update, 3rd edition. Philadelphia: W. B. Saunders, 1988:pp 13–24.
   Google Scholar
• Rocco MB, Barry J, Campbell S, et al. Circadian variation of transient myocardial ischaemia in patients with coronary artery disease. Circulation 1987;75:395–400.
   PubMed Web of Science ®Google Scholar
• Muller JE, Stone PH, Tun ZG, et al. Circadian variation of the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313:135–22.
   Web of Science ®Google Scholar
• Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 1987;60:801–6.
   Google Scholar
• Tsementzis SA, Gill JS, Hitchcock ER, Gill SK, Beevers DG. Diurnal variation of and activity during onset of stroke. Neurosurgery 1985;17:901–4.
   PubMed Web of Science ®Google Scholar
• Brezinski DA, Tofler GH, Muller JE. Morning increase in platelet aggregability; association with assumption of the upright posture. Circulation 1988;78:35–40.
   PubMed Web of Science ®Google Scholar
• Pepine CJ. Circadian variations in myocardial ischemia. Implications for management. JAMA 1991;265:386–90.
   PubMed Web of Science ®Google Scholar
• Degre SGLE. Myocardial ischaemia in 1988. What is it? Acta Cardiol 1988;43:443–8.
   PubMed Web of Science ®Google Scholar
• Mulcahy D, Keegan J, Fox KM. Characteristics of silent and painful ischaemia during ambulatory monitoring in patients with coronary arterial disease. Int J Cardiol 199028:377–9.
   Google Scholar
• Fox KM, Mulcahy DA. Therapeutic rationale for the management of silent ischaemia. Circulation 1990;82(suppl II): II- 155–60.
   Google Scholar
• Deedwania PC, Carbajal EV. Prevalence and patterns of silent myocardial ischemia during daily life in patients receiving conventional antianginal therapy. Am J Cardiol 1990;65:1090–6.
   PubMed Web of Science ®Google Scholar
• Cohn PF. Total ischemic burden, definition, mechanisms and therapeutic implications. Am J Med 1986;81 (Suppl 4A):2-6.
   Google Scholar
• Cowan C. Antianginal drug therapy. Curr Opin Cardiol 19905:453–60.
   Google Scholar
• Sirgo MA, Mills RJ, DeQuattro V. Effects of antihypertensive agents on circadian blood pressure and heart rate patterns - a review. Arch Intern Med 1988; 148:2547–52.
   PubMedGoogle Scholar
• Kostis JB. Comparison of duration of action of atenolol and nadolol for treatment of angina pectoris. Am JCardiol 1988;62:1171–5.
   PubMed Web of Science ®Google Scholar
• Quyyumi AA, Wright C, Mockus L. Effect of partial agonist activity in 8-blockers in severe angina pectoris; a double blind comparison of pindolol and atenolol. Br Med J 1984;289:951–3.
   PubMedGoogle Scholar
• Cohn PF, Lawson WE, Gennaro V, Brady D. Effects of long-acting propranolol on AM and PM peaks in silent myocardial ischaemia. Am J Cardiol 1989;63:872–3.
   PubMed Web of Science ®Google Scholar
• lmperi GA, Lambert CR, Coy K, et al. Effects of titrated beta blockade (metoprolol) on silent myocardial ischemia in ambulatory patients with coronary artery disease. Am J Cardiol 1987;60:519–24.
   PubMed Web of Science ®Google Scholar
• Willich SN, Linderer T, Wegscheider K, et al. Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior β-adrenergic blockade. Circulation 1989;80:853–8.
   PubMed Web of Science ®Google Scholar
• Peters RW, Muller JE, Goldstein S, Byington R, Friedman LM. Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT Study). Am J Cardiol 1989;63:1518–20.
   PubMed Web of Science ®Google Scholar
• Quyyumi AA, Wright C, Mockus L, Shackell M, Sutton GC, Fox KM. Effects of combined alpha and beta adrenoceptor blockade in patients with angina pectoris. Br Heart J 1985;53:47–52.
   PubMedGoogle Scholar
• Crake T, Mulcahy D, Wright C, Fox KM. Labetalol in the treatment of stable exertional angina pectoris: a comparison with nifedipine. Eur Heart J 1988;9:1200–5.
   PubMed Web of Science ®Google Scholar
• Mulcahy D, Cunningham D, Crean P, et al. Circadian variation of total ischaemic burden and its alteration with anti-anginal agents. Lancet 1988;2:755–8.
   PubMed Web of Science ®Google Scholar
• Hill JA, Gonzalez JI, Kolb R, Pepine CJ. Effects of atenolol alone, nifedipine alone and their combination on ambulant myocardial ischemia. Am J Cardiol 1991;67:671–5.
   PubMed Web of Science ®Google Scholar
• Deedwania PC, Carbajal EV, Nelson JR, Hait H. Atenolol is more effective than nifedipine in suppression of spontaneous silent ischemic events during daily life. J Am Coil Cardiol 1991;17:107A.
   Google Scholar
• Nesto RW, Phillips RT, Kett KG, McAuliffe LS, Roberts M, Hegarty P. Effect of nifedipine on total ischemic activity and circadian distribution of myocardial ischemic episodes in angina pectoris. Am J Cardiol 1991;67:128–32.
   PubMed Web of Science ®Google Scholar
• Mann S, Craig MW, Altman DG, et al. The effects of metoprolol on ambulatory blood pressure. Clin Sci 1979;57(suppl5):375S-7.
   Google Scholar
• Fox K, Pool J, Lubsen J. The effects of nisoldipine on the total ischaemic burden: the results of the ROCKET Study. Eur Heart J (in press).
   Google Scholar
• Taylor CR, Gaffney MT, Lahman EA, et al. Effect of amlodipine on circadian rhythm of angina. Presentation at Official Pfizer Inc. sponsored satellite meeting to ESC, Stockholm, 1990.
   Google Scholar
• The Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil lnfarction Trial-DAVIT II). Am J Cardiol 199066:779–85.
   Google Scholar
• Pepine CJ. Clinical effects of calcium antagonists in silent ischaemia. J Curdiovasc Pharmacol 1990;16(suppl 2): S9-12.
   Google Scholar
• Pepine CJ, Hill JA. Medical therapy for silent myocardial ischemia. Circulation 1987;75(suppl II):II-43-4.
   Web of Science ®Google Scholar
• Fox KM, Dargie HJ, Deanfield J, Maseri A. The avoidance of tolerance and lack of rebound using intermittent dose titrated transdermal glyceryl tnnitrate. Br Heart J 1991;66:151–5.
   PubMedGoogle Scholar
• Ridker PM, Manson J, Buring JE, Muller JE, Hennekens CH. Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians. Circulation 1990;82:897–902.
   PubMed Web of Science ®Google Scholar
• Quyyumi AA. Circadian rhythms in cardiovascular disease. Am Heart J 1990;120:726–33.
   PubMed Web of Science ®Google Scholar
• Gould BA, Mann S, Kieso H, et al. The 24-hour ambulatory blood pressure with verapamil. Circulution 1982;65:22–7.
   PubMed Web of Science ®Google Scholar